UCSF’s Safe Motherhood Program and colleagues have tested a novel approach to manage postpartum hemorrhage: ‘secondary prevention/early treatment’ using misoprostol to treat only women with above average bleeding. This study demonstrates secondary prevention/early treatment to be a feasible non-inferior alternative strategy to universally medicating all women who deliver. Read the full article here.